Price T Rowe Associates Inc Wave Life Sciences Ltd. Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 5,098,866 shares of WVE stock, worth $56.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,098,866
Previous 3,126,604 63.08%
Holding current value
$56.8 Million
Previous $25.6 Million 146.01%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$8.0 - $16.44 $15.8 Million - $32.4 Million
1,972,262 Added 63.08%
5,098,866 $63.1 Million
Q3 2024

Nov 14, 2024
BUY
$5.12 - $9.01 $8.64 Million - $15.2 Million
1,687,333 Added 117.24%
3,126,604 $25.6 Million
Q2 2024

Aug 14, 2024
SELL
$4.38 - $6.48 $1.85 Million - $2.73 Million
-421,983 Reduced 22.67%
1,439,271 $7.18 Million
Q1 2024

May 15, 2024
BUY
$3.54 - $6.84 $827,974 - $1.6 Million
233,891 Added 14.37%
1,861,254 $11.5 Million
Q4 2023

Feb 14, 2024
BUY
$4.16 - $6.87 $1.49 Million - $2.46 Million
358,201 Added 28.22%
1,627,363 $8.22 Million
Q3 2023

Nov 14, 2023
BUY
$3.56 - $5.75 $4.32 Million - $6.98 Million
1,213,995 Added 2200.58%
1,269,162 $7.3 Million
Q2 2023

Aug 14, 2023
BUY
$3.51 - $4.69 $65,314 - $87,271
18,608 Added 50.9%
55,167 $201,000
Q1 2023

May 15, 2023
BUY
$3.58 - $6.3 $82,698 - $145,530
23,100 Added 171.63%
36,559 $159,000
Q4 2022

Feb 14, 2023
SELL
$3.18 - $7.0 $94,194 - $207,347
-29,621 Reduced 68.76%
13,459 $94,000
Q3 2022

Nov 14, 2022
BUY
$2.37 - $4.28 $33,417 - $60,348
14,100 Added 48.65%
43,080 $156,000
Q2 2022

Aug 15, 2022
SELL
$1.23 - $3.25 $1,232 - $3,256
-1,002 Reduced 3.34%
28,980 $94,000
Q1 2022

May 16, 2022
BUY
$2.0 - $3.28 $25,600 - $41,984
12,800 Added 74.5%
29,982 $60,000
Q4 2021

Feb 14, 2022
SELL
$3.14 - $5.15 $56,206 - $92,185
-17,900 Reduced 51.02%
17,182 $54,000
Q2 2021

Aug 16, 2021
BUY
$5.65 - $7.47 $27,086 - $35,811
4,794 Added 15.83%
35,082 $234,000
Q1 2021

May 17, 2021
SELL
$5.61 - $12.01 $4.13 Million - $8.84 Million
-736,108 Reduced 96.05%
30,288 $170,000
Q4 2020

Feb 16, 2021
BUY
$6.99 - $9.26 $5.36 Million - $7.1 Million
766,396 New
766,396 $6.03 Million

Others Institutions Holding WVE

# of Institutions
191
Shares Held
122M
Call Options Held
430K
Put Options Held
330K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $966M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email